BMP9 potentiates immunotherapy in triple-negative breast cancer by suppressing Tregs infiltration via the PRKDC-CCL2 axis. You Y, Wei L, Dai M, Zhao G, et al. Cancer Lett 2025;639:218175.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

You Y, Wei L, Dai M, Zhao G, et al. BMP9 potentiates immunotherapy in triple-negative breast cancer by suppressing Tregs infiltration via the PRKDC-CCL2 axis. Cancer Lett 2025;639:218175.
PMID: 41360160